JSPR Earnings

Quarterly EPS
$-37.20
Q3 2024
$-48.58
Q4 2024
$-42.30
Q1 2025
$-52.20
Q2 2025
$-33.90
Q3 2025
$-9.20
Q4 2025
$-1.20
Q1 2026
$-3.00
Q2 2026
Latest RevenueN/A
Latest Net Income-2760000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$3.000-2760000—+94.3%
Q1 2026-$1.200-1174000—+97.2%
Q4 2025-$9.200-9101000—+81.1%
Q3 2025-$33.900-18736000—+8.9%
Q2 2025-$52.200-26723000—-79.4%
Q1 2025-$42.300-21241000—-36.9%
Q4 2024-$48.580-24321000—-8.2%
Q3 2024-$37.200-18637000—+22.5%
Q2 2024-$29.100-14583000——
Q1 2024-$30.900-13728000——
Q4 2023-$44.910-16581000——
Q3 2023-$48.000-17544000——
Jasper Therapeutics (JSPR) — Earnings